Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Endothelial progenitor cells in heart failure patients

EF 2010-11

Résumé
Heart failure is a serious and common disease in Canada. The adequate management of patients with heart failure relies on appropiate prognostic assessments and adequate treatment. Despite the diverse availability of prognostic markers, the progression of this disease is difficult to predict. Therefore, new factors associated to disease stage need to be identified in order to optimize the clinical management of these patients. In the past decade, the existence of bone marrow-derived cells in peripheral blood has been demonstrated. These cells are capable of forming new vessels and repairing dysfunctional ones. These cells have received the name "endothelial progenitor cells". In patients with ischemic heart disease, these cells are associated with the number of cardiovascular risk factors, disease severity and mortality. These findings have opened alternative lanes to understand the complex mechanisms of heart failure and identify new prognostic markers and therapeutic targets. As such, this research proposal will evaluate the relationship between endothelial progenitor cells and clinical characteristics and outcomes in patients with heart failure. Hence, we will explore whether there is an association between the levels of these cells and the functional capacity in patients with heart failure seen at the Toronto General Hospital. Functional capacity will be measured through an exercise test known as a cardiopulmonary study. In addition, we will analyze whether an association exists between the levels of endothelial progenitor cells and outcomes in patients with heart failure. As outcomes, we will evaluate death, heart transplantation, mechanical heart implantation, the development of potentially lethal arrhythmias and hospital admissions due to decompensated heart failure. Our study will help to better characterize the association between these cells and heart failure stage and potentially identify new prognostic markers and therapeutic options.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229578
Name
Alba Ana Carolina
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Endothelial progenitor cells in heart failure patients
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Endothelial Progenitor Cells; Functional Capacity; Heart Failure; Mortality; Prognosis; Survival
Abstract
Heart failure is a serious and common disease in Canada. The adequate management of patients with heart failure relies on appropiate prognostic assessments and adequate treatment. Despite the diverse availability of prognostic markers, the progression of this disease is difficult to predict. Therefore, new factors associated to disease stage need to be identified in order to optimize the clinical management of these patients. In the past decade, the existence of bone marrow-derived cells in peripheral blood has been demonstrated. These cells are capable of forming new vessels and repairing dysfunctional ones. These cells have received the name "endothelial progenitor cells". In patients with ischemic heart disease, these cells are associated with the number of cardiovascular risk factors, disease severity and mortality. These findings have opened alternative lanes to understand the complex mechanisms of heart failure and identify new prognostic markers and therapeutic targets. As such, this research proposal will evaluate the relationship between endothelial progenitor cells and clinical characteristics and outcomes in patients with heart failure. Hence, we will explore whether there is an association between the levels of these cells and the functional capacity in patients with heart failure seen at the Toronto General Hospital. Functional capacity will be measured through an exercise test known as a cardiopulmonary study. In addition, we will analyze whether an association exists between the levels of endothelial progenitor cells and outcomes in patients with heart failure. As outcomes, we will evaluate death, heart transplantation, mechanical heart implantation, the development of potentially lethal arrhythmias and hospital admissions due to decompensated heart failure. Our study will help to better characterize the association between these cells and heart failure stage and potentially identify new prognostic markers and therapeutic options.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Alba, Ana Carolina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~